Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
112,550
Sort by:
2019 Herpes Zoster (Shingles) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
... the Herpes Zoster (Shingles) pipeline companies from advancing their products. Herpes Zoster (Shingles) Report Description The H1-2019 pipeline review report on Herpes Zoster (Shingles) is ... license providers and universities participating in the Herpes Zoster (Shingles) product pipeline are provided. Company ...
March 2019
45 pages
2019 Human herpesvirus 4(HHV-4) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
... the Human herpesvirus 4(HHV-4) pipeline companies from advancing their products. Human herpesvirus 4(HHV-4) Report Description The H1-2019 pipeline review report on Human herpesvirus 4(HHV-4) ... providers and universities participating in the Human herpesvirus 4(HHV-4) product pipeline are provided. Company ...
March 2019
90 pages
2019 Influenza B virus Infections R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
... Influenza B virus Infections pipeline companies from advancing their products. Influenza B virus Infections Report Description The H1-2019 pipeline review report on Influenza B virus Infections ... providers and universities participating in the Influenza B virus Infections product pipeline are provided. Company ...
March 2019
95 pages
2019 Iron Deficiency Anemia R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
... the Iron Deficiency Anemia pipeline companies from advancing their products. Iron Deficiency Anemia Report Description The H1-2019 pipeline review report on Iron Deficiency Anemia is ... license providers and universities participating in the Iron Deficiency Anemia product pipeline are provided. Company overview, ...
March 2019
56 pages
2019 Onychomycosis (Nail fungus) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
... the Onychomycosis (Nail fungus) pipeline companies from advancing their products. Onychomycosis (Nail fungus) Report Description The H1-2019 pipeline review report on Onychomycosis (Nail fungus) ... providers and universities participating in the Onychomycosis (Nail fungus) product pipeline are provided. Company ...
March 2019
55 pages
2019 Pertussis (Whooping Cough) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
... the Pertussis (Whooping Cough) pipeline companies from advancing their products. Pertussis (Whooping Cough) Report Description The H1-2019 pipeline review report on Pertussis (Whooping Cough) ... providers and universities participating in the Pertussis (Whooping Cough) product pipeline are provided. Company ...
March 2019
72 pages
2019 Rubella (German Measles) R&D Pipeline Drugs, Companies, Trials and Developments
US$ 2,199.00
... the Rubella (German Measles) pipeline companies from advancing their products. Rubella (German Measles) Report Description The H1-2019 pipeline review report on Rubella (German Measles) is ... license providers and universities participating in the Rubella (German Measles) product pipeline are provided. Company ...
March 2019
40 pages
